文献速递颅颌面外科显微修复重建创面修复

Ferroximend改善放疗大鼠下颌骨非血管化骨移植整合

Ferroximend Improves Nonvascularized Bone Graft Incorporation in the Irradiated Rat Mandible.
PubMed 文献 · Ann Plast Surg · 2025-01-01

本研究在大鼠下颌骨临界尺寸缺损模型中,评估可植入性去铁胺-透明质酸偶联物Ferroximend对放疗后非血管化骨移植整合的治疗作用。放疗组和FER组接受70 Gy照射,结果显示Ferroximend显著改善影像学与生物力学指标,FER组骨愈合率89% vs XRT组39%,与对照组94%无显著差异。提示Ferroximend可能逆转放疗对骨移植整合的损害。

要点

  • 放疗(70 Gy)损害大鼠下颌骨非血管化骨移植的整合。
  • Ferroximend植入显著改善放疗后骨移植的影像学和生物力学指标。
  • FER组骨愈合率89% vs XRT组39%,与对照组94%无显著差异。

核心结论

  • Ferroximend植入可在非血管化骨移植重建中修复放疗的损害作用,临床转化后可能使患者受益于放疗后肿瘤重建中非血管化骨移植的重新引入。

研究设计与样本

  • 三组Lewis大鼠(每组n=8):对照组、放疗组(XRT)和Ferroximend组(FER)。
  • XRT和FER组左侧半下颌骨接受人等效剂量70 Gy放疗。
  • 所有组创建6 mm圆形临界尺寸缺损并以骨移植修复。
  • 第15、40、60天进行活体μCT成像并分析放射形态学指标。
  • 收获标本后,由3名盲法评审员评估骨性愈合,随后进行生物力学测试。

主要发现

  • 放疗损害骨移植整合,表现为第40天和第60天放射形态学和生物力学指标下降。
  • 放疗后植入Ferroximend与未植入的放疗动物相比,显著改善放射形态学和生物力学强度指标。
  • FER组骨愈合率89% vs XRT组39%,差异有统计学和临床意义;FER组与对照组94%无显著差异。

临床怎么用

  • 原文未报告临床实践推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this work is to therapeutically reverse the damaging effects of radiotherapy on bone graft incorporation to enable nonvascularized bone grafting (NVBG) in the irradiated mandible. While NVBG has lost favor as a surgical reconstructive method in irradiated bone, it offers advantages to the current gold standard free tissue transfer, as it is less invasive and avoids the need for complex microsurgery. Therapeutically, fortifying the NVBG technique with angiogenic stimulants may offer avenues for the reintroduction of this practical method of surgical reconstruction.Utilizing a rodent model of mandibular bone grafting and established standard outcome measures, we quantified metrics of diminished graft take and bone healing as a consequence of radiotherapy (XRT). We hypothesized that the addition of Ferroximend, a novel implantable formulation of angiogenic deferoxamine conjugated to hyaluronic acid, would demonstrate substantial, clinically relevant degrees of remediation on the process of bone graft incorporation in the aftermath of radiation injury. MATERIALS AND METHODS: Three groups of Lewis rats were investigated (n = 8/group): control, XRT, and Ferroximend (FER). The XRT and FER groups received a human equivalent dose of 70 gray (Gy) of radiotherapy to left hemi-mandibles. In all groups, a circular 6-mm critical sized defect was created and repaired with a bone graft. Mandibles were imaged at 15, 40, and 60 days with in vivo μCT and radiomorphometrics were analyzed. Upon harvest, bony union was assessed by 3 blinded reviewers prior to biomechanical testing. RESULTS: Radiation impaired bone graft incorporation as evidenced by diminished radiomorphometrics and biomechanical metrics at 40 and 60 days. Ferroximend implantation after radiotherapy significantly improved radiomorphometrics and metrics of biomechanical strength when compared to irradiated, nonimplanted animals. Notably, the bony union percentage of the FER group demonstrated both statistical and clinically significant improvement when compared to the XRT group (89% vs 39%, respectively) and was not significantly different than control animals (94%). CONCLUSIONS: Our results suggest that the implantation of Ferroximend during NVBG reconstruction can remediate the damaging effects of radiotherapy. Upon clinical translation, countless patients may benefit from the successful reintroduction of nonvascularized bone grafting as a reconstructive option in oncologic reconstruction after radiotherapy.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Lalchandani KB, Donneys A, Nelson NS, et al. Ferroximend Improves Nonvascularized Bone Graft Incorporation in the Irradiated Rat Mandible. Ann Plast Surg. 2025. PMID: 40498974. doi:10.1097/SAP.0000000000004355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。